The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABAA receptors after chronic ethanol exposure

Journal of Neurochemistry

Volumn 102, Issue 3, 2007, Pages 741-752

  Warnault, Vincent ^a,b   Houchi, Hakim ^a,b   Barbier, Estelle ^a,b   Pierrefiche, Olivier ^a,b   Vilpoux, Catherine ^a,b   Ledent, Catherine ^c   Daoust, Martine ^a,b   Naassila, Mickaël ^a,b  

^a INSERM   (France)

^b FR 114 Lille   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cannabinoid; CB1 receptor; Chronic ethanol; Knockout; NMDA

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CANNABINOID 1 RECEPTOR; DIAZEPAM; DIZOCILPINE; ENDOCANNABINOID; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PENTOBARBITAL; TRITIUM;

ADAPTATION; ALCOHOLISM; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA CHAIN; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; GENOTYPE; HIPPOCAMPUS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

MUS;

EID: 34447298598     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04577.x     Document Type: Article

References (64)

1. Allali-Hassani A., Martinez S. E., Peralba J. M., Vaglenova J., Vidal F., Richart C., Farres J. Pares X. (1997) Alcohol dehydrogenase of human and rat blood vessels. Role in ethanol metabolism. FEBS Lett. 405, 26 30.
2. Arnone M., Maruani J., Chaperon F., Thiebot M. H., Poncelet M., Soubrie P. Le Fur G. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl.) 132, 104 106.
3. Basavarajappa B. S., Saito M., Cooper T. B. Hungund B. L. (2000) Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim. Biophys. Acta 1535, 78 86.
4. Basavarajappa B. S., Saito M., Cooper T. B. Hungund B. L. (2003) Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur. J. Pharmacol. 466, 73 83.
5. Basavarajappa B. S., Yalamanchili R., Cravatt B. F., Cooper T. B. Hungund B. L. (2006) Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 50, 834 844.
6. Baskfield C. Y., Martin B. R. Wiley J. L. (2004) Differential effects of delta-9-tetrahydrocannabinol and methanandamide on operant behavior in CB1 knockout and wild type mice. J. Pharmacol. Exp. Ther. 309, 86 91.
7. Blednov Y. A., Jung S., Alva H., Wallace D., Rosahl T., Whiting P. J. Harris R.H. (2003) Deletion of the α1 or β2 subunit of GABAA receptors Reduces actions of alcohol and other drugs. J. Pharmacol. Exp. Ther. 304, 30 36.
8. Buck K. J. Hood H. M. (1998) Genetic association of a GABAA receptor 2 subunit variant with severity of acute physiological dependence on alcohol. Mamm. Genome 9, 975 978.
9. Cohen C., Perrault G., Voltz C., Steinberg R. Soubrie P. (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav. Pharmacol. 13, 451 463.
10. Colombo G., Agabio R. Fa M. (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol. 33, 126 130.
11. Comings D. E., Muhleman D., Gade R., Johnson P., Verde R., Saucier G. MacMurray J. (1997) Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol. Psychiatry 2, 161 168.
12. Crabbe J. C. Phillips T.J. (2004) Pharmacogenetic studies of alcohol self-administration and withdrawal. Psychopharmacology (Berl.) 174, 539 560.
13. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J. P., Belzung C., Fritschy J. M., Luscher B. Mohler H. (1999) Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2, 833 839.
14. Criswell H. E., Johnson K. B., Mueller R. A. Breese G. R. (1993) Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-d-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J. Pharmacol. Exp. Ther. 265, 1001 1010.
15. De Witte P. (2004) Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict. Behav. 29, 1325 1339.
16. Faingold C. L., N'Gouemo P. Riaz A. (1998) Ethanol and neurotransmitter interactions-from molecular to integrative effects. Prog. Neurobiol. 55, 509 535.
17. Floyd D. W., Jung K. Y. McCool B. A. (2003) Chronic ethanol ingestion facilitates N-methyl-d-aspartate receptor function and expression in rat lateral/basolateral amygdala neurons. J. Pharmacol. Exp. Ther. 307, 1020 1029.
18. Gallate J. E. McGregor I. S. (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology (Berl.) 142, 302 308.
19. Gallate J. E., Saharov T., Mallet P. E. McGregor I. S. (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur. J. Pharmacol. 370, 233 240.
20. Gardner E. L. (2005) Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 81, 263 284.
21. Gulya K., Grant K. A., Valverius P., Hoffman P. L. Tabakoff B. (1991) Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 547, 129 134.
22. Hansson A. C., Bermudez-Silva F. J., Malinen H., Hyytia P., Sanchez-Vera I., Rimondini R., Rodriguez de Fonseca F., Kunos G., Sommer W. H. Heilig M. (2007) Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference. Neuropsychopharmacology 32, 117 126.
23. Hodge C. W. Cox A. A. (1998) The discriminative stimulus effects of ethanol are mediated by NMDA and GABA(A) receptors in specific limbic brain regions. Psychopharmacology 139, 95 107.
24. Hodge C. W., Chappelle A. M. Samson H. H. (1995) GABAergic transmission in the nucleus accumbens is involved in the termination of ethanol self-administration in rats. Alcohol. Clin. Exp. Res. 19, 1486 1493.
25. Houchi H., Babovic D., Pierrefiche O., Ledent C., Daoust M. Naassila M. (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30, 339 349.
26. Hungund B. L., Basavarajappa B. S., Vadasz C., Kunos G., Rodriguez de Fonseca F., Colombo G., Serra S., Parsons L. Koob G. F. (2002) Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcohol. Clin. Exp. Res. 26, 565 574.
27. Hungund B. L., Szakall I., Adam A., Basavarajappa B. S. Vadasz C. (2003) Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J. Neurochem. 84, 698 704.
28. Johnston G. A. R. (1996) GABAA receptor pharmacology. Pharmacol. Ther. 69, 173 198.
29. Krystal J. H., Staley J., Mason G., Petrakis I. L., Kaufman J., Harris R. A., Gelernter J. Lappalainen J. (2006) Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch. Gen. Psychiatry 63, 957 968.
30. Ledent C., Valverde O., Cossu G. et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401 404.
31. Low K., Crestani F., Keist R. et al. (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131 134.
32. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 275.
33. Maldonado R., Valverde O. Berrendero F. (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 29, 225 232.
34. Malinowska B., Napiorkowska-Pawlak D., Pawlak R., Buczko W. Gothert M. (1999) Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration. Eur. J. Pharmacol. 377, 13 19.
35. McKernan R. M., Rosahl T. W., Reynolds D. S. et al. (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat. Neurosci. 3, 587 592.
36. Mechoulam R. Parker L. (2003) Cannabis and alcohol - a close friendship. Trends Pharmacol. Sci. 24, 266 268.
37. Mehta A. K. Ticku M. K. (1998) Chronic ethanol administration alters the modulatory effect of 5alpha-pregnan-3alpha-ol-20-one on the binding characteristics of various radioligands of GABAA receptors. Brain Res. 805, 88 94.
38. Mehta A. K. Ticku M. K. (2005) Effect of chronic administration of ethanol on GABAA receptor assemblies derived from alpha2-, alpha3-, beta2- and gamma2-subunits in the rat cerebral cortex. Brain Res. 1031, 134 137.
39. Naassila M. Daoust M. (2002) Effect of prenatal and postnatal ethanol exposure on the developmental profile of mRNAs encoding NMDA receptor subunits in rat hippocampus. J. Neurochem. 80, 850 860.
40. Naassila M., Ledent C. Daoust M. (2002) Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J. Neurosci. 22, 1087 1093.
41. Naassila M., Pierrefiche O., Ledent C. Daoust M. (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46, 243 253.
42. Nakki R., Wong G. Korpi E. R. (1995) [3H]MK-801 binding in various brain regions of rat lines selected for differential alcohol sensitivity. Alcohol 12, 335 340.
43. Negro M., Chinchetru M. A., Fernandez A. Calvo P. (1995) Effect of ethanol treatment on rate and equilibrium constants for [3H] muscimol binding to rat brain membranes: alteration of two affinity states of the GABAA receptor. J. Neurochem. 64, 1379 1389.
44. Perra S., Pillolla G., Melis M., Muntoni A. L., Gessa G. L. Pistis M. (2005) Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology (Berl.) 183, 368 377.
45. Poncelet M., Maruani J., Calassi R. Soubrie P. (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci. Lett. 343, 216 218.
46. Preuss U. W., Koller G., Zill P., Bondy B. Soyka M. (2003) Alcoholism related phenotypes and genetic variants of the CB1 receptor. Eur. Arch. Psychiat. Clin. Neurosci. 253, 275 280.
47. Pritchett D. B., Sontheimer H., Shivers B. D., Ymer S., Kettenmann H., Schofield P. R. Seeburg P. H. (1989) Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature (Lond.) 338, 582 585.
48. Reibaud M., Obinu M. C., Ledent C., Parmentier M., Bohme G.A. Imperato A. (1999) Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol. 379, R1 R2.
49. Reynolds D. S., Rosahl T. W. Cirone J. (2003) Sedation and anesthesia mediated by distinct GABAA receptor isoforms. J. Neurosci. 23, 8608 8617.
50. Rhodes J. S., Best K., Belknap J. K., Finn D. A. Crabbe J. C. (2005) Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol. Behav. 84, 53 63.
51. Rodriguez de Fonseca F., Roberts A. J., Bilbao A. Koob G. F. (1999) Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Acta Pharmacol. Sin. 20, 1109 1114.
52. Rodriguez-Paz J. M., Anantharam V. Treistman S. N. (1995) Block of the N-methyl-d-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing. Neurosci. Lett. 190, 147 150.
53. Ron D. (2004) Signaling cascades regulating NMDA receptor sensitivity to ethanol. Neuroscientist 10, 325 336.
54. Schmidt L. G., Samochowiec J., Finckh U., Fiszer-Piosik E., Horodnicki J., Wendel B., Rommelspacher H. Hoehe M. R. (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend. 65, 221 224.
55. Serra S., Brunetti G., Pani M., Vacca G., Carai M. A., Gessa G. L. Colombo G. (2002) Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur. J. Pharmacol. 443, 95 97.
56. Sucher N. J., Awobuluyi M., Choi Y. B. Lipton S. A. (1996) NMDA receptors: from genes to channels. Trends Pharmacol. Sci. 17, 348 355.
57. Tang Y. P., Shimizu E., Dube G. R., Rampon C., Kerchner G. A., Zhuo M., Liu G. Tsien J. Z. (1999) Genetic enhancement of learning and memory in mice. Nature (Lond.) 401, 63 69.
58. Urigüen L., Pérez-Rial S., Ledent C., Palomo T. Manzanares J. (2004) Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46, 966 973.
59. Urigüen L., Berrendero F., Ledent C., Maldonado R. Manzanares J. (2005) Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice. Eur. J. Neurosci. 22, 2106 2110.
60. Varvel S. A. Lichtman A. H. (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J. Pharmacol. Exp. Ther. 301, 915 924.
61. Velardo M. J., Simpson V. J. Zahniser N. R. (1998) Differences in NMDA receptor antagonist-induced locomotor activity and [3H]MK-801 binding sites in short-sleep and long-sleep mice. Alcohol. Clin. Exp. Res. 22, 1509 1515.
62. Vinod K. Y., Yalamanchili R., Xie S., Cooper T. B. Hungund B. L. (2006) Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem. Int. 49, 619 625.
63. Wang L., Liu J., Harvey-White J., Zimmer A. Kunos G. (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl Acad. Sci. USA 100, 1393 1398.
64. Wingrove P. B., Thompson S. A., Wafford K. A. Whiting P. J. (1997) Key amino acids in the α subunit of the γ-aminobutyric acid A receptor that determine ligand binding and modulation at the benzodiazepine site. Mol. Pharmacol. 52, 874 881.